Bardon, Australia

Mark Leslie Smythe

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 124(Granted Patents)


Location History:

  • Queensland, AU (2010)
  • Bardon, AU (2006 - 2023)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovator Mark Leslie Smythe: Pioneering Hepcidin Analogues

Introduction

Mark Leslie Smythe, located in Bardon, Australia, is a prominent inventor known for his contributions to the field of biomedical science. With an impressive portfolio of 14 patents, Smythe's innovations largely focus on hepcidin analogues and their therapeutic applications. His work has significant implications for treating various disorders linked to iron overload.

Latest Patents

Among his latest patents are “Hepcidin analogues and uses thereof,” which pertains to specific hepcidin peptide analogues, including peptides and dimers. This invention aims at providing treatments for conditions such as hereditary hemochromatosis and iron-loading anemias. Additionally, he has patented “Conjugated hepcidin mimetics,” which presents improved hepcidin analogues designed with enhanced in vivo half-lives, along with pharmaceutical compositions that utilize these novel compounds.

Career Highlights

Smythe has had a notable career working with organizations that drive innovation in biomedical research. He has been affiliated with Protagonist Therapeutics, Inc., where he contributed to advancing peptide therapies. Additionally, his time at The University of Queensland has allowed him to collaborate with leading researchers and foster academic advancements in the field.

Collaborations

Throughout his career, Smythe has collaborated with talented individuals such as Gregory Thomas Bourne and Brian Troy Frederick. These partnerships have been instrumental in developing effective therapies and pushing the boundaries of existing scientific knowledge.

Conclusion

Mark Leslie Smythe stands out as a significant figure in the realm of biotechnology and pharmaceuticals. His innovative patents in hepcidin analogues not only contribute to scientific understanding but also hold promise for improving patient care in managing iron overload diseases. As advancements continue to emerge from his work, the impact of his inventions will likely be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…